Safety and efficacy of mTOR Inhibitor (sirolimus or everolimus) in patients with intestine and multivisceral transplantation: A retrospective multicenter study
Latest Information Update: 11 Oct 2019
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Intestinal transplant rejection
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 11 Oct 2019 New trial record